TERM PAPER GlaxoSmithKline Bangladesh Limited.docx
Transcript of TERM PAPER GlaxoSmithKline Bangladesh Limited.docx
TERM PAPER
ON
GlaxoSmithKline Bangladesh Limited
CHAPTER 01
INTRODUCTION
1.1 INTRODUCTION
Bangladesh, after achieving birth in 1971 had become a fascinating body by the Multinational Companies. As capitalization is going on through the world the MNCs are given an unwritten license to expand their business
1 | P a g e
over the world. In this sequel action American Life Insurance Company ltd. Launched in Bangladesh as a first ever MNC. Since then to today around 100 MNC have been competing in Bangladesh.
Pharmaceutical Industry is one of the highly sophisticated industries in Bangladesh which has been uncovered to rapid change and made a revolution in Bangladesh by maintaining high technology and a world class standard in quality. These industries have a major commitment to the society than any other industries as it is involved with the manufacturing of life saving drugs.
GlaxoSmithKline Bangladesh Limited is a fast growing, trusted, and emerging pharmaceutical that develops, manufacture, markets and distributes quality assured best in class pharmaceutical products in Bangladesh. GSK try to be improving the quality of human life by enabling people to do more, feel better, live longer. The company’s principal activities include secondary manufacture of pharmaceutical products and marketing of vaccines, pharmaceutical healthcare products and health food drinks.
GlaxoSmithKline is one of the leading multinational companies in the world. Their marketing and promotional activities are different from others. Stiefel, a GSK company, have prescription and non-prescription products. However, GSK trying to make different promotional activities to make the consumer more aware about the non-prescription skin products. Their promotional activities spread on three categories, For Doctor, Chemist and for final consumer. GSK taken different policy for consumer awareness.
1.2 Scope & Objectives Of The Study
My broad objective is to know the multinational companies internal and
external communication process in both home and host country. What is
the marketing policy that they apply for success in the host country? How
a multinational company adapt in the host country culture.
The scope of this term research paper is to present the text contents from
different source rather than fully textual basis. The company’s website,
company profile by employees are found to complete this term research
2 | P a g e
paper. The scope of arranging the term research paper is condensed that
the scope is only limited to secondary source of cyber information.
1.3 Methodology of the Study
As I mentioned earlier, that the prime source for the term research paper
content is the secondary source called internet. It is really not easy to find
the ultimate information from internet. The searching criteria must be
different. There are various types of PDF and document files which contain
only the text I have typed in the search box but the rest of the file is
totally useless for the term research paper. The search for Power Point
Slides also helps to understand the main points and probable information
which I need to present on the term research paper. The PowerPoint also
helps to get the graphs and statistics in an easy way.
1.4 Limitation of the Study
There were many limitations in preparing the term research paper. The
PDF files, websites, PowerPoint presentation, various document files are
gathered from the foremost source, Internet. The time limitation was the
big issue. The final examinations of the semester were there that it
impeded the arrangement of the term research paper information in
various ways. Study took almost all portion of time that’s why the term
research paper was made in significantly short time.
3 | P a g e
CHAPTER 02
DISCUSSION : AN OVERVIEW
OF GLAXOSMITHLINE
2.1 An Overview GlaxoSmithKline Global
4 | P a g e
GlaxoSmithKline (GSK) is a world’s leading research-based pharmaceutical
company, along with in the area of Health care with a powerful
combination of skills and resources that provides a platform for delivering
strong growth in today’s rapidly changing healthcare environment.
GlaxoSmithKline A subsidiary of GlaxoSmithKline (GSK) is one of the
world’s largest research based pharmaceutical and healthcare companies
GSK, continues to be committed to improving the quality of human life by
enabling people to do more, feel better and live longer. The Company’s
principle activities include secondary manufacture of pharmaceutical
products and marketing of vaccines, pharmaceutical and healthcare
products.
GSK has leadership in four major therapeutic areas- anti invectives,
central nervous system
(CNS) and respiratory & gastro- intestinal/ metabolic. In addition it is a
leader in the important areas of vaccines and has growing portfolio of
oncology product. With the pharmaceutical products, GSK produces a lot
of health care products including the renowned brands such as Horlicks,
Boost, Viva, Glaxose, Maltova, Eno, Sensodyne. GSK supplies products to
140 global markets and has over 100,000 employees worldwide. GSK has
180 manufacturing site in 41 countries.
2.1.1 History of GlaxoSmithKline
Henry Wellcome and Silas Burroughs founded Glaxo in 1880. Glaxo
established medicine research centre around the world. In the Thirties,
GSK introduced improved technology to the business. The business grew
and new ventures were bought in UK. Glaxo Wellcome and SmithKline
Beecham announced their intention to merge on 17 January 2000. The
merger was completed in December that year, forming GlaxoSmithKline
(GSK). Companies were competing for the same raw materials, both were
involved in large-scale marketing of medicine produce and both used
5 | P a g e
similar distribution channels. Between them, they had operations in over
76 countries.
SmithKline Beecham grew through mergers with other medicine
companies in the 1920s. In a history that now crosses three centuries,
GSK's success has been influenced by the major events of the day –
economic boom, depression, world wars, changing consumer lifestyles
and advances in technology. And throughout they've created 5 products
that help people get more out of life – Health Food Drinks, Oral Care,
Vitamins Minerals Supplement and Instant Powder Drink. Through this
timeline you'll see how GSK brand portfolio has evolved. At the beginning
of the 21st century, path to Growth strategy focused us on global high-
potential brands and Vitality mission is taking us into a new phase of
development. More than ever, how brands are helping people 'Do More
Feel Better Live Longer' – a slogan that is visible to the main street of
Bunny Thorpe that is over a hundred years ago.
Timeline
In 1830 : John K Smith opens a Drugstore in Philadelphia.
In 1842: Thomas Beecham launches Beecham’s pills in England.
In 1880: Burroughs Wellcome & Company was founded.
In 1891: SmithKline & Co. acquires French, Richards & Company.
In 1906: Glaxos registered by Joseph Nathan & Company as a trademark
for dried milk.
In 1935: The importance of the pharmaceutical market was soon realized
and in 1935, Glaxo Laboratories Limited was founded with its
headquarters at Greenford, Middlesex and London for the production and
marketing of foods and pharmaceuticals.
In 1947: After the 2nd world war, Glaxo developed rapidly. Glaxo
Laboratories Limited absorbed its parent Joseph Nathan & Company, and
became a public company in 1947.
6 | P a g e
In 1963: Edinburgh Pharmaceutical Industries Limited, which owned
Duncan, Flockhart and Company Limited and MAC Farlane Smith Limited,
joined Glaxo.
In 1995: Glaxo acquired 100% share, of Wellcomes PLC on May 01, 1995
and formed GlaxoWellcome PLC.
In 2000: GlaxoWellcome and SmithKline Beecham merged to form
GlaxoSmithKline; a worldwide research based pharmaceutical company.
2.1.2 Ownership structure
GlaxoSmithKline is a public limited company. Ordinary shares are traded
on the London Stock Exchange (ticker symbol GSK). American Depositary
Shares (ADSs), representing two ordinary shares, are traded on the New
York Stock Exchange (ticker symbol GSK).
Some shareholders favour a pro-active company approach towards health
problems in developing countries. The Pharmaceutical Shareholders
Group, a London-based group of large institutional investors that hold
shares of pharmaceutical companies, studied the business rationale for
addressing the issue and assessed how well companies are managing
this. In a recently published a report, it recommends companies to
7 | P a g e
develop a pro-active, comprehensive and consistent approach to address
these problems and identifies best practices. GSK was identified as one of
the leading companies, but the report also mentioned that all companies
could still improve their approach.
The California Public Employees Retirement System (Calpers) is estimated
to hold over 700 million US$ of GlaxoSmithKline stock (less than 1%). In
April 2003, Calpers used this position to call upon GSK to make its
HIV/AIDS available in the developing world at lower prices.
2.1.3 Business profile
GlaxoSmithKline (GSK) is one of the world’s largest research-based
pharmaceutical companies that that discovers, develops, manufactures
and markets human health products. It is an innovative company that
produces branded products only, which it has developed itself.
The company has two main divisions, pharmaceuticals and consumer
healthcare. The consumer healthcare businesses of GSK consist of over-
the-counter (OTC) medicines, oral care products, such as the toothpaste
brands Aquafresh, Macleans and Sensodyne, and nutritional healthcare
drinks. The pharmaceuticals division is the largest part of GSK’s
businesses and can be divided into prescription drugs and vaccines. This
report deals with the pharmaceuticals division only. The headquarters of
GSK are located in the UK, with additional operational headquarters in the
USA. The company operates in some 160 national markets, the major
ones being the USA, Japan, France, Germany, the UK and Italy.
GSK conducts R&D at more than 20 sites and employs 15,000 employees
in R&D.
The principal facilities are located in UK, USA, Japan, Italy and Belgium,
and minor R&D sites are located in Canada, France and Spain. All R&D for
vaccines is carried out in Belgium. GSK is involved in many different R&D
partnerships with academic institutions, biotechnology companies and
8 | P a g e
other pharmaceutical companies. The company has a leading position in
genetics and in new drug discovery technologies. The manufacture and
supply system of GSK operates as a single global network. The company
has 87 manufacturing sites and employs around 32,000 employees in
production. It has two types of manufacturing sites. Primary
manufacturing sites produce the active compounds used in the drugs.
There are twelve of these sites, located in the UK, Ireland, the USA,
Singapore and Australia. Secondary manufacturing sites convert the
active compounds into finished products. There are 15 of these sites in
Europe, 6 in North America, 5 in Latin America, 5 in the Middle East and
Africa, 15 in the Asia/Pacific/Australia Region, 4 in China, and 1 in Japan.
Vaccine manufacturing is primarily located at two sites in Belgium. GSK
employs 44,000 people in sales and has the largest sales force in the
pharmaceutical industry. It has various co-marketing and co-promotion
agreements with other pharmaceutical companies.
2.1.4 Business strategy
GSK’s business goal is to be a world leader in pharmaceutical industry. In
order to achieve this, the company seeks to improve its R&D pipeline,
using a focused drug portfolio strategy and selective in-licensing
agreements for the external contracting of R&D. The company links R&D
closely to commercial operations to maximize the value of its R&D
portfolio. Furthermore, GSK seeks to increase brand name recognition
among customers and to develop improved versions of older products, on
which new patents can be obtained. It is a common strategy of branded
drug producers to develop improved versions or more convenient
formulations of drugs on which the patents have expired, and to persuade
doctors and patients to use the enhanced version. Direct-to-consumer
(DTC) advertising is an important element of GSK’s marketing strategy in
the US. Consumers that receive information through DTC advertising tend
to request specific brand name medicines to their physicians. The
company is implementing a ‘sales force excellence’ initiative to improve
the already good reputation of GSK sales representatives among
helathcare professionals. It has also started a ‘marketing excellence’
9 | P a g e
initiative to reduce the number of patients that do not seek the help of a
doctor and remain undiagnosed, and the number of diagnosed patients
that remain untreated.
2.1.5 Marketing Strategy
GlaxoSmithKline marketing strategy is directly linked to its corporate
strategy. The following points illustrate GlaxoSmithKline official strategic
priorities as mentioned in company website and corresponding points in
marketing strategy of the company:
a) Growing diversified global businesses: In other words,
GlaxoSmithKline product differentiation and market expansion plays an
integral role within the corporate strategy. This specific corporate strategy
finds its echo within GlaxoSmithKline strategic marketing through
positioning the company as the largest drug manufacturer with the widest
ranges of products in emerging markets such as China, Turkey and India.
b) Delivering more products of value: This specific strategy can be
interpreted as achieving an effective combination of quality and price for
GlaxoSmithKline products. This strategy has been linked to
GlaxoSmithKline marketing strategy through communicating the massage
about effective combination of quality and price for
GlaxoSmithKline products with the use of various marketing
communication channels in an integrated manner.
c) Simplifying the company’s operational model: To be constantly
aiming for high level of efficiency in various organizational processes.
GlaxoSmithKline’s reliance on digital marketing for a range of products
such as Oral Care due to the high level of efficiency of this marketing
platform highlights the link between the company’s strategic marketing
and corporate strategy.
10 | P a g e
2.1.6 PESTEL Analysis
The level of implementation of GlaxoSmithKline (GSK) marketing strategy
is subject to a range of external and internal factors that shape overall
marketing environment for the business. PESTEL strategic analytical tool
can be used to study the impacts of external factors to the business
where the abbreviation stands for political, economic, social,
technological, ecological, and legal factors.
Political factors affecting the implementation of GSK marketing strategy
include possible changes in international trade regulation and competitive
regulation likely to be introduced by the governments of China and India.
Economic factors impacting GSK marketing strategy include high rate of
economic growth in China and India. Moreover, current economic
uncertainties associated with European markets might have negative
implications on the marketing strategy
Social factors with potential implications on GSK marketing strategy are
changes in consumer lifestyles, shifts in consumer attitudes and opinions
etc. However, Cameron (2012) specifies increasing level of customer
resentment towards large amounts of profits made by pharmaceutical
companies and sliding images of large pharmaceutical companies as the
most significant social factor in the current environment.
Technological factors include breakthroughs in pharmaceutical industry,
issues associated with licensing and patenting drug manufacturing
technology, as well as, the level of development of industry technology.
Ecological factors also have specific implications on GSK marketing
strategy that include problems related to global warming, and impact to
the environment of GSK activities, and the reaction of stakeholders to this
impact.
11 | P a g e
Legal factors as one of the most important factors involve rules and
regulations directly and indirectly related to GSK operations in local
markets, as well as, European law and international trade rules,
regulations and agreements.
2.1.7 SWOT Analysis
SWOT stands for strengths, weaknesses, opportunities, and threats
associated with a business and it is an effective strategic analytical tool
used to assess businesses. The following table illustrates GlaxoSmithKline
SWOT Analysis:
Strengths
Increased level of R&D potential
Strong financial position
Global coverage with presence in more than 100 countries
Weaknesses
Considerable damage made to brand image because of Avandia
drug scandal
Ineffective online presence
Low level of flexibility due to the large size of the company
Opportunities
Increasing the level of presence in China and India
Following diversification strategy
Improving the level of online presence
Threats
Lawsuits to damage the brand image
12 | P a g e
New competitors joining the market
Worsening of economic situation in Europe
2.1.8 Culture and Behavior
GSK’s mission is to improve the standard of human living by enabling the
people to do more, feel better and live long.
Culture and behavior of organization play a vital role in the prosperity of
the organization which that is going to be expected with its staff’s is also
expected from their staff that they must be from the point of Culture
Dedicated to their job/company.
Be focused on patient.
Integrity with job.
According to Behavior
Market Leadership
Innovative thinking
Quality of as a team member
2.1.9 Communication
GlaxoSmithKline has a challenging and inspiring mission to improve the
quality of human life by enabling people to do more, feel better and live
longer. The end objective of GlaxoSmithKline’s communication is to
transmit the information on company’s identity conveyed in the mission
statement and Spirit of GSK values of ‘respect for people, patient focus,
integrity, and transparency to create and maintain positive image of the
business counterbalancing common unfavorable perceptions of the
company.
Simultaneous communication goals include generating product
awareness, informing the stakeholders on company’s financial tenure, and
developing brand and corporate image to generate sales. Considering the
13 | P a g e
nature of GSK’s business and heavy regulatory burden significant part of
the product communication is devoted to the informative imperative.
Internal-Operational Communication: GSK has an internal
communication system which holds the employee communicates each
other on the platform of GSK.
There are so many platforms to communicate like as:
CEO engages a plat form from all over the world of 250 top people
from different sections of the company to help the strategic change
in different sectors of the company.
A CEO advisory board which helps the CEO from their ideas from
across the world is also established.
The online version of magazine is published on the 100% recycled
paper.
An online access on GSK TV to download the views and progress
inside the company.
GSK has also an internal business communication system via
intranet through that the messages, meeting across worldwide be
conducted.
External-Operational Communication: To communicate the
values constituting the center of company’s identity to key audiences in
distinctive manner, however maintaining overall integrity of the
communicate GlaxoSmithKline divides the function into operational units
overseen by the Board, reflecting key stakeholder groups.
The media unit is responsible for crisis management. Additionally, the
company devotes one division to managing dissemination of information
on CSR activities, which suggests company’s realization of the social
responsibility’s potential to add value to the business’s reputation.
14 | P a g e
Website Prominence of consumers actively searching information online
on products and ethical standards of their providers enables GSK to use
the website to disseminate favorable message in a fully controlled
environment.
Press releases are applied to communicate with media journalists and
investors, serving the purpose of quick dissemination of vital positive
information, or rapid response to issues and crises arising
Direct-to-consumer advertising GSK extensively applies direct-to-
consumer advertising within the US market, taking the lead among Big
Pharmas in marketing expenditure.
GSK as a buyer of the raw materials, manufactured goods and services
around the world has a better relationship according to the human rights
commission.
GSK aims to have a good relationship with the local communities.
GSK publish information on all our work with patient groups, including
details of the funding received.
2.2 An Overview GlaxoSmithKline Bangladesh LTD.
GlaxoSmithKline(GSK) Bangladesh Limited carries with it an enviable
image and reputation for the past 6 decades. A subsidiary of
GlaxoSmithKline plc- one of the world's leading research-based
pharmaceutical and healthcare companies GSK Bangladesh, continues to
be committed to improving the quality of human life by enabling people to
do more, feel better and live longer. The Company’s principle activities
include secondary manufacture of pharmaceutical products and
15 | P a g e
marketing of vaccines, pharmaceutical healthcare products and health
food drinks.
2.2.1 History of GlaxoSmithKline Bangladesh LTD.
GlaxoSmithKline is the leading and largest pharmaceutical company in
Bangladesh. After independence of Bangladesh, it was a Glaxo subsidiary
and in 1974 Glaxo Bangladesh limited was established as a Company. In
1969 a supporting factory of Glaxo Laboratories (Pakistan) Ltd. was
formed in Chittagong.
In the year 1951, Glaxo Laboratories (Pakistan) Ltd. started its sales office
at Chittagong. Later on Branch sales office were started in Dhaka and
Khulna respectively.
The construction of Chittagong Factory Building was started in 1958 and
completed in 1965. Factory started its production in 1967 with foods and
pharmaceuticals.
The factory of the company is situated at Chittagong and its marketing
Directorate is based in the capital city of Dhaka.
At the beginning of the factory there were around 250 workers /
employees in the company. At present the employee strength of the
company is about 800. It has 12 sales deports in different district towns of
the country covering most of the areas of the country. It facilitated the
customers to get the company products as their premises within shortest
possible time at the company cost.
GSK Bd. Ltd. produces baby foods, Glucose, Antibiotics and
pharmaceuticals. It has 67 items.
In 1996 it has been incorporated as GlaxoWellcome Bangladesh Limited
and in October 2002 it has been incorporated as GlaxoSmithKline
Bangladesh Limited. The corporate office and Marketing division shifted to
Dhaka in 1998. The factory is in a two storied building on 67000 sq. meter
of land. 82% of its share belongs to group and the remaining 18% belong
to the Bangladeshi companies and various individuals.
16 | P a g e
2.2.2 Business profile
GlaxoSmithKline Bangladesh Limited is managed by the Board of Directors
and the Company Executive Committee (CEC).
The Board of Directors is ultimately accountable for the Company's
activities, strategy and financial performance.
Board of Directors
Company Executive Committee
Board of Directors:
Chairman
Managing Director
Directors – 2 non-Executive Directors & 2 Executive Directors
Functions and Responsibility of Directors:
Production Director: To meet the Target production Quantity
Marketing Director: To monitor the Market demand and ensure the supply
appropriately.
Finance Director: To look after the financial position of the company.
Quality Assurance Director: To assurance quality.
The Company’s philosophy of Corporate Governance is aimed at assisting
the management of the Company in the efficient conduct of its business
and in meeting its obligations to stakeholders, and is guided by a strong
emphasis on transparency, accountability and integrity. For several years,
the Company has adopted a codified Corporate Governance Charter,
which is in line with the best practice, as well as meets all the relevant
17 | P a g e
legal and regulatory requirements. All employees are bound by Codes of
Conduct that sets forth the Company’s policies on all important issues.
2.2.3 Business strategy
a. Functional level strategies: GlaxoSmithKline Bangladesh Ltd follows
different functional level strategies to gain competitive advantages and
sustain it in the long run in the matured industries. They increase their
efficiency through exploiting economies of scale and learning effects. For
Example: Invested £3.4 billion in 2013 in our search to develop new
medicines, vaccines and consumer products. They carry out extensive
research to innovate new products and modify the existing products to
better satisfy the consumers.
b. Business-Level Strategies: GlaxoSmithKline strategic managers
adopt different business level strategies to use the company’s resources
and distinctive competencies to gain competitive advantage over its
rivals. These are:
They follow cost-leadership strategy as they have intermittent over
capacity and the ability to gain economies of scale. This way they
can produce cost effective products and yet be profitable.
They also target different market segments with different products
to have broad product line. By product proliferation they reduce the
threat of entry and expand the range of products they make to fill a
wide variety of niches.
c. Strategy in the Global Environment: GlaxoSmithKline Bangladesh
Ltd. is registered under GlaxoSmithKline plc. As a part of a global
company it follows some generalized strategies and principals of
GlaxoSmithKline. However, they also modify different strategies based on
the national conditions. The different strategies that they follow in the
global environment are stated below:
They import the raw materials from the places where it is less
costly, thus achieve
18 | P a g e
location economy.
GSK follows a multi domestic strategy where the companies
extensively customize both their product offering and marketing
strategy to different national conditions.
d. Corporate strategy: GSK carries out the following corporate level
strategies:
They have a diversified business. GSK has reflected the changing
market dynamics there and to prepare for the launch of multiple
new products. GSK are restructuring to improve efficiency and focus
resources to growth opportunities in what continues to be a
challenging market environment.
GSK have changed the traditional R&D so that it is better able to
sustain a pipeline of products that offer valuable improvements in
treatment for patients and healthcare providers.
As business continues to change shape, GSK is transforming so that
it can reduce
complexity and become more efficient.
2.2.4 Marketing Strategy
The pharmaceutical industry has limited field of marketing. Yet in an age
high competition like todays, firms are heavily spending and effectively
practicing marketing. GSK believe that through their business they make a
valuable contribution to society by developing and marketing medicines
which improve people’s lives. Their philosophy is to target support to
selected programs that are innovative, sustainable and which produce
tangible results. GSK’s tagline in Bangladesh is “Do more, feel better, live
longer”. Before selling its product GSK makes sure that all its products are
registered with drug registration according to the Drug Control Ordinance.
GSK sells its product through its own sales offices. It has its own
distribution network with 12 departments and a field force consisting of
19 | P a g e
125 medical representatives. The summary of marketing functions is
given below:
Designing and implementing sales strategies.
Controlling and updating distribution network.
Designing and carrying out promotional programs.
Providing marketing information services.
Carrying out different awareness programs.
Controlling international trades.
Keeping records of data regarding marketing activities.
Building up public communication network.
Looking after all the brands and patents.
Conducting marketing surveys as needed.
2.2.5 PESTEL Analysis
PESTEL analysis provides a framework to examine the external
environment of a company. PESTEL stands for political, economical, social,
technological, environmental and legal factors. PESTEL analysis helps a
company to categorize the relevant issues in its environment, so that it
can assess its relative importance and develop an appropriate strategy.
The following sections provides an overview of the currently affecting the
GlaxoSmithKline in Bangladesh.
Political factors: Experienced international businesses engage in
political risk assessment, a systematic analysis of the political risks they
face in foreign countries and any changes in the political environment that
may adversely affect the value of a company’s business activities.
Politically Bangladesh is now a stable country after decades of instability
20 | P a g e
and coups. Bangladesh government regards the pharmaceutical industry
as one of the key sector for foreign investment in the country. With strong
government support Bangladesh is developing a robust manufacturing
and technically experienced industrial base for this sector. General strikes
by opposite political parties those caused huge loss to the businesses and
industries were a regular part of political life in Bangladesh. Companies
are still facing some corruption and bureaucracy issues when to do
business in Bangladesh. Despite some bureaucratic problems in overall
the current political environment of Bangladesh is business-friendly for
GlaxoSmithKline.
Economic factors: When a company wants to do business in
another country, it should have good knowledge on growth rate, inflation,
unemployment, wages, income, stability, poverty and the like of that
country. The economy of Bangladesh has grown 5-6% per year since 1996
despite many internal problems like political instability, poor
infrastructure, corruption, and insufficient power supplies and its growth
was resilient during the 2008-09 global financial crisis and recession.
Inflation rate is a measure of the increase in the cost of living that
influence on many parts of the economic confidence, and the stability.
Higher inflation rate raises the cost of living and historically annual
inflation rates of 10 to 30 percent, erodes confidence in a country’s
currency and spurs people to search for better ways to store value. Lower
inflation is a good indicator for GlaxoSmithKline’s Bangladesh
marketplace. The proportion of unemployed workers in a country shows
how well a country productively uses its human resources. In Bangladesh
unemployed workers do not get any benefits or allowances from the
government. The larger the total debt becomes, the more uncertain a
country’s economy becomes. The resulting pressure to revise government
policies, in the face of growing internal debt, can create economic
uncertainties for investors and companies. For the pharmaceutical
industry, the cost of labour is one of the key elements of total production
21 | P a g e
costs. This is accounted for Bangladesh’s highly competitive labour and
energy costs.
Socio-cultural factors: A company should identify key cultural
differences in the country where it is doing or intended to do business and
then it must need to alter its customary practices to succeed there. There
is a long tradition of self-medication in Bangladesh as many of its
population cannot afford to see health professionals when they fall ill.
According to the World Factbook (2010), 89.5% of the population in
Bangladesh is Muslim. The religious belief and practices have influence
and impact on national/international business that is seen in a culture’s
values and attributes toward entrepreneurship, consumption and social
organization. Many Muslim workers require extra time break for daily
prayer. Muslims are forbidden from the consumption of pork and alcohol.
Bangladesh tops South Asia with its average life expectancy of 61 years
though per capita consumption of medication is one of the lowest in the
region.
Technological factors: Technological environment is another
important dimension of a country and the foundation of its resource base.
Foreign direct investment has brought about the globalization of
production, but this has not led to the globalization of technological
innovation in Bangladesh. Bangladeshi pharmaceutical firms target mainly
lower-end branded generics. Around 80% of Bangladesh’s total need of
Active Pharmaceutical Ingredient (API) is being met through imports (UKTI,
2010). To meet the API demand locally the Bangladesh government is
developing an API park, that is due to open in 2011 to meet at least 70%
of country’s API supplies and it will develop the infrastructure with state-
of-the-art facilities including a central effluent treatment plant and
incinerator for solid and liquid waste-management (BOI, 2010b). Novartis
and other pharmaceutical companies in Bangladesh will be benefited from
this park to minimize their production cost by using locally produced APIs.
22 | P a g e
Environmental factors: Couple of key environmental factors
discussed in following sections those significant for Novartis operation in
Bangladesh. Bangladesh is now widely recognized to be one of the
countries which are most vulnerable to climate change as a result of
global warming. Natural hazards that come from increased rainfall, rising
sea levels, and tropical cyclones are expected to increase as climate
change, each seriously affecting agriculture, water & food security, human
health and shelter.
Legal factors: Every company in every country must comply with
local legal system and regulations regarding operations. The legal
environment has a great impact on doing business in any country.
According to the World Bank (2009) reports Bangladesh is ranked 119 out
of 183 economies on ease of doing business whereas India ranked 133 .
2.2.6 SWOT Analysis
Strengths:
1. Reputation management on RD and Production only.
2. Sound capital base.
3. Good infrastructure.
4. Large market share.
5. Large highly skilled work force.
6. Wide range of products and mix edge drugs down to toothpaste.
7. Globally positioned in the pharmaceutical industry.
Weaknesses:
1. Low market dominance.
2. No online presence.
3. Inconsistency of attractive promotions.
4. Patent expiry for a number of bulk-buster products.
23 | P a g e
Opportunities:
1. Emerging markets and expansion abroad.
2. Developing vaccines for persistent diseases.
3. Global penetration through mergers and acquisitions.
4. Strategic agreements with other pharmaceutical companies and
organizations to boost its research.
Threats:
1. Lower cost competitors or imports.
2. Counterfeit drugs being sold in competition with legitimate products.
3. Political pressure to sell at prices that fail to pay for the development of
new drugs or to recover past development costs.
4. Patent expiry on drugs that generate strong income.
5. Increasing cost of drug trials (research) and ever higher standards
imposed by national drug approvals bodies.
6. Economic slowdown in European markets.
2.2.7 Culture and Behavior
Bangladesh, as well as the US and UK, is a masculine culture, so it fits
Hofstede’s profile when it comes to behavior and promotion of respect in
the workplace, as it is a feminine trait to be tender and nurturing, not a
masculine one. As for Hall’s insider/outsider-dimension, low context
cultures do not distinguish closely between insiders and outsiders, and
therefore people of all backgrounds and levels have the possibility of
being respected in the same way.
According to Greet Hofstede, Bangladesh scores high on power distance,
it’s about 80, which means that people accept a hierarchical order in
which everybody has a place and which needs no further justification.
Hierarchy in an organization is seen as reflecting inherent inequalities,
24 | P a g e
centralization is popular, subordinates expect to be told what to do and
the ideal boss is a benevolent autocrat.
In case of individualism, Bangladesh scores about 20 which are
considered a collectivistic society.
Bangladesh scores 55 on masculinity and can be considered a masculine
society. In masculine countries people “live in order to work”,
managers are expected to be influential and assertive, the emphasis is on
equity, competition and performance and conflicts are resolved by
fighting them out.
Bangladesh scores 60 on uncertainty avoidance and thus has a high
preference for avoiding uncertainty.
In long term orientation, Bangladesh scores 40, in this dimension which
reflects it a short term orientation culture.
Societies with a short-term orientation generally show great respect for
traditions, a relatively small propensity to save, strong social pressure to
“keep up with the Joneses”, impatience for achieving quick results,
and a strong concern with establishing the Truth.
In Bangladesh, GSK has adopted a four step approach towards the
initiation of cultural change. This change process has been slightly
modified from the force field analysis proposed by (Lewin 1951) to fit the
change situation of GSK. The steps that were undertaken by the company
can be summarized in the form of following diagram:
These four steps cover the following four points:
25 | P a g e
1. Make sure that the R&D department and people understand the
pressure of change – why do we need to change?
2. Develop and share a clear vision about where the organization
and department is headed – where are we going?
3. Put in place the individual, departmental and organizational
capabilities for change – what do we need to make the change?
4. Have a plan of action that outlines what has to be done to get it all
started – what do we have to do tomorrow when we come to
work?
In terms of recruitment process, GSK use the common form such as
application forms, phone interview, and on-site interviews. GSK
Bangladesh do not employ recent graduates, only qualified and skilled
employees. In Bangladesh, GSK gives preference to both internal and
external sources for recruiting managers and specialists. GSK Bangladesh
uses Pay for Performance, where an employee’s wage is gradually
increased when his team or organization as a whole achieves certain
goals. This means that the pay increase in Bangladesh is dependent on
that of a group, rather than individual performance.
In addition to national culture, there are also other things like economic
systems, legal frameworks, human capital, and social environment that
influence HR management practices. In Bangladesh, investment is
allocated by a fixed rate of 20 per cent of Bangladesh’ profits in the
healthcare infrastructure, regardless of ROI level. Bangladesh’s focus on
scaling down prices for years to come - knowing that this will lead to lower
levels of sales volume (as it did, based on the annual report) – is
contradictory to Hofstede’s short term orientation because of the focus on
the future.
One of the main reason for the successful adaptation in Bangladesh of
GSK because GSK BD believes in recruitment from the Bangladesh. A
large number of employee has been recruited from the local market. More
26 | P a g e
over GSK Bangladesh has a huge participation in different national social
work.
The communication styles of Bangladeshi people are indirect or implicit.
They usually take longtime to know each other; they love to use rich and
contextualized words. If someone take short time or direct approach in
introduction, they considered as rude. Personal space is not a huge factor
in Bangladeshi culture, they tend to stand or close (2-3 feet) when taking.
Touch of same gender is common in Bangladesh usually in female. All of
the friends and family members take along conversation period in
meeting each other or taking via network; this approach happened
because Bangladeshi believes in collectivism approach.
2.2.8 Communication
Communication is a very important thing for a company like GSK BD. The
headquarter of the company situated in Gulshan, Dhaka whereas all the
other twelve District Marketing Offices (DMO) situated throughout the
Country and These are divided in five zones by which GSK’s products are
sold. So to communicate with each other they need some advance
technology and easy communication process.
Internal-Operational Communication: Internal-Operational
Communication are those which is used in conducting work within a
business. That is the communication among the business employee’s that
is done to create, implement and track the success of the business’s
operating plan. Now-a-days technology plays a very important role in
internal-operational communication.
There are so many platforms to communicate like as:
Board of Directors holds periodic meetings to resolve issue of
policies and strategies, recording minutes/decisions for
implementation by the Executive Management.
The Managing Director heads the Executive Management, the Chief
Executive Officer (CEO) who has been delegated necessary and
27 | P a g e
adequate authority by the Board of Directors. The Executive
Management operates through further delegations of authority at
every echelon of the line management.
There are five major departments and each departments and each
departments of GSK operates in different aspects but they are
interrelated as well as complement to each other.
HR department of GSK administrate smooth workflow in the
organization and manages the demands of the labors in the factory.
Because of the advancement of the technology now-a-days any kind
of communication can be made through land phone or cellular
phone.
For any kind of brief information employees can use electronic mail
or even fax.
Employees can use their own web portal for many important things.
GlaxoSmithKline encourage open network communication usually. In this
communication network employees can frequently communicate their
views and perception without so much formal network.
External-Operational Communication: External-operational
communication is work-related communication with people outside the
business such as personal selling, telephoning, advertising and writing
message. For meeting up with the necessary information to the market
GSK BD has medical promotion officer. Their main duties are as follows :
Meet and approach customers actively and energetically.
Get the job done with professional standard.
Seek, share and adopt successful practices in the team.
Meet commitment and deliver results on time and travel
extensively.
GSK as a buyer of the raw materials, manufactured goods and services
around the world has a better relationship according to the human rights
28 | P a g e
commission. GSK aims to have a good relationship with the local
communities. GSK wants to minimize the influence on the local
communities and aim to prosperity of the area.
2.2.9 Communication Networks
There are two complex network of information in virtually any
organization. One of them is formal and the other one is informal. The
formal network consists of the official, more stable lines of
communication. Each company has its preferred communication forms or
genres, for conducting its business. The formal network of GSK BD is
mentioned in the below figure:
29 | P a g e
On the other hand the informal network, consisting largely of personal
communications, is highly complex and ever changing.
30 | P a g e
CHAPTER 03
EVALUATION
&
CONCLUSION
3.1 Evaluation
The only introduction of an effective communication system within the
organizational system cannot bring the efficient results for the
organization. For the achievement of the success of a communication
planning within the organization, the following steps or measures will be
counted:
31 | P a g e
For the first time the organization will implement the planning within
the organizational system.
At this stage the organization will collect the feedbacks of the
application of the new plan of communication.
To generate the valid information regarding the effectiveness of the
process will be assessed here.
Now the information generated from feedback of the application of
communication planning will be evaluated through the comparison
of the result with the standard result wanted.
From the analysis, the pitfalls of the planning will be identified and
will be rectified to establish the proper control on the success of the
communication process.
Feedback system of GSK Bangladesh Limited follows smart techniques.
Those are given below :
GKS global intranet site provides news and updates and a Q&A
section where employees can put questions directly to the CEO and
other senior executives. Up to 100 questions are answered each
month.
During the year, supervisor provides performance feedback to the
employee. Directors and above have to pass under 360 degree
feedback systems.360 Degree
Feedback is a system or process in which employees receive
confidential, anonymous feedback from the people who work around
them. This typically includes the employee's manager, peers, and
direct reports.
A mixture of about eight to twelve people fill out an anonymous
online feedback form that asks questions covering a broad range of
workplace competencies. The feedback forms include questions that
are measured on a rating scale and also ask raters to provide
written comments. The person receiving feedback also fills out a
self-rating survey that includes the same survey questions that
others receive in their forms.
32 | P a g e
Managers and leaders of GSK Bangladesh use 360 feedback surveys
to get a better understanding of their strengths and weaknesses.
The 360 feedback system automatically tabulates the results and
presents those in a format that helps the feedback recipient create
a development plan.
Townhall sessions for employees at all levels of the company,
hosted by senior management including the CEO. Employees have
the opportunity to discuss the progress of the business, raise
questions and give feedback.
Employee surveys are carried out regularly throughout the
organization to enable staff to give feedback. A global survey of
managers is carried out every two years.
Confidential feedback mechanisms enable employees to raise
concerns. These include our integrity helpline.
3.2 Conclusion
GlaxoSmithKline is one of the most prominent multinational
Pharmaceuticals Company in Bangladesh was established to provides a
good and sound health protection medicine to our people. Being a
multinational company it faces some restrictions by local drug
administration, as there is a bar to produce some costly but profitable
products that are produced by local companies. Moreover, its standard
operating procedures products manufacturer it is always concerned about
the highest quality of its products. Now it is not utilizing its full production
capacity. Because of its firm attitude toward quality, its production cost is
increased and hence it is becoming in competitive in the market for some
products. It can regain it market share if it can procure raw materials at
lower cost. Moreover, it needs to take aggressive sales promotion
program to increase sales.
Communication management is an important area of business
management. While selecting any system or procedure of communication
management must consider its users and many cross cultural differences
33 | P a g e
of information. An effective communication is free from different
communication noise. So an effective communication can bring
organizational success and increase positive motivation in workplace. So
communication strategy should be made with due concentration on
internal and external facts and forces.
In time, it can be said that GlaxoSmithKline Bangladesh Limited has
created leadership position in pharmaceutical field through its high quality
products, services, and research and development programs. However, it
should maintain its existing goodwill as well as improve its market share
to survive.
References
www.gsk.com.bd
34 | P a g e
www.gsk.com
Armstrong, M. Baron. A, Managing Performance, Performance
Management in Action, P23-40
Zaman, L. Case Study on GlaxoSmithKline Bangladesh Limited; Vol.
1, No, 1; September 11
Employee Guide to Business Conduct; Ninth Edition. P32-35
GSK Corporate Responsibility Report; 2004; 12-16
Vanguard University; Performance Management Process; P2-10
http://www.businessballs.com/performanceappraisals.htm
http://www.performance-appraisal.com/intro.htm
http://en.wikipedia.org/wiki/Performance_appraisal
http://www.managementstudyguide.com/performance-appraisal-
tools.htm
http://www.scribd.com/doc/30633194/PROS-and-CONS-
Managements-by-Objectives
Gary Dessler, eleventh edition, Human Resource Management,
Prentice Hall of India
GlaxoSmithKline, Bangladesh, Limited Annual report-2011
Appendices
Appendix A
35 | P a g e
GSK- It is the short version or abbreviation of GlaxoSmithKline.
Appendix B
Annual report: An annual report is a comprehensive report on a
company's activities throughout the preceding year. Annual reports are
intended to give shareholders and other interested people information
about the company's activities and financial performance.
36 | P a g e